The ECFS-CTN cannot guarantee that the information provided here is comprehensive. Please go to the ClinicalTrials.gov link for detailed and up-to-date information on study background, eligibility criteria, study design, outcome measures, study status, participating sites, sponsor contact information and timelines.
You can also contact the CTN coordinating centre for additional information: ECFS-CTN@uzleuven.be
| Study Name on ClinicalTrials.gov (link is external) |
Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis |
|---|---|
| Study Drug | Lenabasum |
| Type of Study Drug | Anti-inflammatory |
| Study Title | A Multicenter, Randomized, Double-Blind, Placebo-Controlled Phase 2 Trial to Evaluate Efficacy and Safety of Lenabasum in Cystic Fibrosis |
| Study Phase | 2 |
| Study Sponsor | Corbus Pharmaceuticals |
| Participating ECFS-CTN sites | Please contact ecfs-ctn@uzleuven.be for most recent sitelist |
| Age | ≥12 years of age |